Expression analysis of secreted and cell surface genes of five transformed human cell lines and derivative xenograft tumors

BMC Genomics

Volumn 6, Issue , 2005, Pages

  Stull, Robert A ^a   Tavassoli, Roya ^a   Kennedy, Scot ^a   Osborn, Steve ^a   Harte, Rachel ^a   Lu, Yan ^a   Napier, Cheryl ^b   Abo, Arie ^a   Chin, Daniel J ^a  

^a Pharmaceutical Product Development   (United States)

^b Piedmont Research Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOGENIC PROTEIN; BIOLOGICAL MARKER; CELL SURFACE PROTEIN; SCLEROPROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BREAST CARCINOMA; CARCINOMA CELL; CELL LINE; CELL TRANSFORMATION; CELLULAR DISTRIBUTION; COLON CARCINOMA; CONTROLLED STUDY; DISCRIMINANT ANALYSIS; DNA MICROARRAY; FEMALE; GENE EXPRESSION PROFILING; GENE IDENTIFICATION; HUMAN; HUMAN CELL; LUNG CARCINOMA; MALE; MOUSE; MULTIVARIATE ANALYSIS OF VARIANCE; NONHUMAN; OVARY CARCINOMA; POLYMERASE CHAIN REACTION; PROSTATE CARCINOMA; PROTEIN LOCALIZATION; PROTEIN SECRETION; QUANTITATIVE ANALYSIS; TUMOR XENOGRAFT;

EID: 25444450616     PISSN: 14712164     EISSN: 14712164     Source Type: Journal    
DOI: 10.1186/1471-2164-6-55     Document Type: Article

References (56)

1. Paget S: The distribution of secondary growths in cancer of the breast. Lancet 1889, 1:571-3.
2. Khong HT, Restifo NP: Natural selection of tumor variants in the generation of "tumor escape" phenotypes. Nat Immunol 2002, 3:999-1005.
3. Bergers G, Benjamin LE: Tumorigenesis and the angiogenic switch. Nat Rev Cancer 2003, 3:401-10.
4. Glinsky GV, Krones-Herzig A, Glinskii AB, Gebauer G: Microarray analysis of xenograft-derived cancer cell lines representing multiple experimental models of human prostate cancer. Mol Carcinog 2003, 37:209-21.
5. Pedersen N, Mortensen S, Sorensen SB, Pedersen MW, Rieneck K, Bovin LF, Poulsen HS: Transcriptional gene expression profiling of small cell lung cancer cells. Cancer Res 2003, 63:1943-53.
6. Creighton C, Kuick R, Misek DE, Rickman DS, Brichory FM, Rouillard JM, Omenn GS, Hanash S: Profiling of pathway-specific changes in gene expression following growth of human cancer cell lines transplanted into mice. Genome Biol 2003, 4:R46.
7. Perou CM, et al.: Molecular portraits of human breast tumours. Nature 2000, 406:747-52.
8. Dhanasekaran SM, Barrette TR, Ghosh D, Shah R, Varambally S, Kurachi K, Pienta KJ, Rubin MA, Chinnaiyan AM: Delineation of prognostic biomarkers in prostate cancer. Nature 2001, 412:822-6.
9. Fidler IJ: The pathogenesis of cancer metastasis: the "seed and soil" hypothesis revisted. Nature Reviews 2003, 3:453-8.
10. Holash J, Wiegand SJ, Yancopoulos GD: New model of tumor angiogenesis: dynamic balance between vessel regression and growth mediated by angiopoietins and VEGF. Oncogene 1999, 18:5356-62.
11. Vajkoczy P, Farhadi M, Gaumann A, Heidenreich R, Erber R, Wunder A, Tonn JC, Menger MD, Breier G: Microtumor growth initiates angiogenic sprouting with simultaneous expression of VEGF, VEGF receptor-2, and angiopoietin-2. J Clin Invest 2002, 109:777-85.
12. Benjamin LE, Hemo I, Keshet E: A plasticity window for blood vessel remodelling is defined by pericyte coverage of the preformed endothelial network and is regulated by PDGF-B and VEGF. Development 1998, 125:1591-8.
13. Gerhardt H, Betsholtz C: Endothelial-pericyte interactions in angiogenesis. Cell Tissue Res 2003, 314:15-23.
14. Shirakawa K, Wakasugi H, Heike Y, Watanabe I, Yamada S, Saito K, Konishi F: Vasculogenic mimicry and pseudo-comedo formation in breast cancer. Int J Cancer 2002, 99:821-8.
15. Aonuma M, Iwahana M, Nakayama Y, Hirotani K, Hattori C, Murakami K, Shibuya M, Tanaka NG: Tumorigenicity depends on angiogenic potential of tumor cells: dominant role of vascular endothelial growth factor and/or fibroblast growth factors produced by tumor cells. Angiogenesis 1998, 2:57-66.
16. Hattori K, et al.: Vascular endothelial growth factor and angiopoietin-1 stimulate postnatal hematopoiesis by recruitment of vasculogenic and hematopoietic cells. J Exp Med 2001, 193:1005-14.
17. Ekstrand AJ, Cao R, Bjorndahl M, Nystrom S, Jonsson-Rylander AC, Hassani H, Hallberg B, Nordlander M, Cao Y: Deletion of neuropeptide Y (NPY) 2 receptor in mice results in blockage of NPY-induced angiogenesis and delayed wound healing. Proc Natl Acad Sci USA 2003, 100:6033-8.
18. Maeshima Y, Colorado PC, Torre A, Holthaus KA, Grunkemeyer JA, Ericksen MB, Hopfer H, Xiao Y, Stillman IE, Kalluri R: Distinct antitumor properties of a type IV collagen domain derived from basement membrane. J Biol Chem 2000, 275:21340-8.
19. Mallet C, Feraud O, Ouengue-Mbele G, Gaillard I, Sappay N, Vittet D, Vilgrain I: Differential expression of VEGF receptors in adrenal atrophy induced by dexamethasone: a protective role of ACTH. Am J Physiol Endocrinol Metab 2003, 284:E156-67.
20. Giard DJ, Aaronson SA, Todaro GJ, Arnstein P, Kersey JH, Dosik H, Parks WP: In vitro cultivation of human tumors: establishment of cell lines derived from a series of solid tumors. J Natl Cancer Inst 1973, 51:1417-23.
21. Cailleau R, Young R, Olive M, Reeves WJ: Breast tumor cell lines from pleural effusions. J Natl Cancer Inst 1974, 53:661-74.
22. Kaighn ME, Narayan KS, Ohnuki Y, Lechner JF, Jones LW: Establishment and characterization of a human prostatic carcinoma cell line (PC-3). Invest Urol 1979, 17:16-23.
23. Gene Ontology [http://wwwgeneontology.org/]
24. Kerr MK, Churchill GA: Experimental design for gene expression microarrays. Biostatistics 2001, 2:183-201.
25. Osborn S, Kennedy S, Chin D: A flexible pipeline for experimental design processing and analysis of microarray data. In IEEE Comp Systems Bioinformatics IEEE Computer Society, Los Alamitos, CA; 2003:411-412.
26. Lenburg ME, Liou LS, Gerry NP, Frampton GM, Cohen HT, Christman MF: Previously unidentified changes in renal cell carcinoma gene expression identified by parametric analysis of microarray data. BMC Cancer 2003, 3:31.
27. Perou CM, et al.: Distinctive gene expression patterns in human mammary epithelial cells and breast cancers. Proc Natl Acad Sci USA 1999, 96:9212-7.
28. Su AI, et al.: Molecular classification of human carcinomas by use of gene expression signatures. Cancer Res 2001, 61:7388-93.
29. Yoon JC, Chickering TW, Rosen ED, Dussault B, Qin Y, Soukas A, Friedman JM, Holmes WE, Spiegelman BM: Peroxisome proliferator-activated receptor gamma target gene encoding a novel angiopoietin-related protein associated with adipose differentiation. Molec Cell Biol 2000, 20:5343-5349.
30. Le Jan S, et al.: Angiopoietin-like 4 is a proangiogenic factor produced during ischemia and in conventional renal cell carcinoma. Am J Pathol 2003, 162:1521-8.
31. Yoshida K, Shimizugawa T, Ono M, Furukawa H: Angiopoietin-like protein 4 is a potent hyperlipidemia-inducing factor in mice and inhibitor of lipoprotein lipase. J Lipid Res 2002, 43:1770-2.
32. Harada S, Nagy JA, Sullivan KA, Thomas KA, Endo N, Rodan GA, Rodan SB: Induction of vascular endothelial growth factor expression by prostaglandin E2 and E1 in osteoblasts. J Clin Invest 1994, 93:2490-6.
33. Gallo O, Franchi A, Magnelli L, Sardi I, Vannacci A, Boddi V, Chiarugi V, Masini E: Cyclooxygenase-2 pathway correlates with VEGF expression in head and neck cancer Implications for tumor angiogenesis and metastasis. Neoplasia 2001, 3:53-61.
34. Fukuda R, Kelly B, Semenza GL: Vascular endothelial growth factor gene expression in colon cancer cells exposed to prostaglandin E2 is mediated by hypoxia-inducible factor 1. Cancer Res 2003, 63:2330-4.
35. Oh Y, Nagalla SR, Yamanaka Y, Kim HS, Wilson E, Rosenfeld RG: Synthesis and characterization of insulin-like growth factor-binding protein (IGFBP)-7 Recombinant human mac25 protein specifically binds IGF-I and -II. J Biol Chem 1996, 271:30322-5.
36. Yamauchi T, Umeda F, Masakado M, Isaji M, Mizushima S, Nawata H: Purification and molecular cloning of prostacyclin-stimulating factor from serum-free conditioned medium of human diploid fibroblast cells. Biochem J 1994, 303:591-8.
37. Carson-Walter EB, Watkins DN, Nanda A, Vogelstein B, Kinzler KW, St Croix G: Cell surface tumor endothelial markers are conserved in mice and humans. Cancer Res 2001, 61:6649-55.
38. Hendrix MJ, Seftor EA, Hess AR, Seftor RE: Molecular plasticity of human melanoma cells. Oncogene 2003, 22:3070-5.
39. Gillis P, Savla U, Volpert OV, Jimenez B, Waters CM, Panos RJ, Bouck NP: Keratinocyte growth factor induces angiogenesis and protects endothelial barrier function. J Cell Sci 1999, 112:2049-57.
40. Zukowska-Grojec Z, Dayao EK, Karwatowska-Prokopczuk E, Hauser GJ, Doods HN: Stress-induced mesenteric vasoconstriction in rats is mediated by neuropeptide Y Y1 receptors. Am J Physiol 1996, 270:H796-800.
41. Lee EW, et al.: Neuropeptide Y induces ischemic angiogenesis and restores function of ischemic skeletal muscles. J Clin Invest 2003, 111:1853-62.
42. Soker S, Takashima S, Miao HQ, Neufeld G, Klagsbrun M: Neuropilin-1 is expressed by endothelial and tumor cells as an isoform-specific receptor for vascular endothelial growth factor. Cell 1998, 92:735-45.
43. Hampe W, Rezgaoui M, Hermans-Borgmeyer I, Schaller HC: The genes for the human VPS10 domain-containing receptors are large and contain many small exons. Hum Genet 2001, 08:529-36.
44. Lintzel J, Franke I, Riedel IB, Schaller HC, Hampe W: Characterization of the VPS10 domain of SorLA/LR11 as binding site for the neuropeptide HA. Biol Chem 2002, 383:1727-33.
45. Vincent JP, Mazella J, Kitabgi P: Neurotensin and neurotensin receptors. Trends Pharmacol Sci 1999, 20:302-9.
46. Levine L, Lucci JA, Pazdrak B, Cheng JZ, Guo YS, Townsend CM, Hellmich MR: Bombesin stimulates nuclear factor kappa B activation and expression of proangiogenic factors in prostate cancer cells. Cancer Res 2003, 63:3495-502.
47. Hoos A, Urist MJ, Stojadinovic A, Mastorides S, Dudas ME, Leung DH, Kuo D, Brennan MF, Lewis JJ, Cordon-Cardo C: Validation of tissue microarrays for immunohistochemical profiling of cancer specimens using the example of human fibroblastic tumors. Am J Pathol 2001, 158:1245-51.
48. Petricoin EF, et al.: Use of proteomic patterns in serum to identify ovarian cancer. Lancet 2002, 359:572-7.
49. Swiss-Prot [http://www.expasy.org/sprot/]
50. UCSC Genome [http://www.genome.ucsc.edu/]
51. GPCR Database [http://www.gpcr.org]
52. NIH Blast [http://www.ncbi.nlm.nih.gov/blast]
53. MySQL [http://sourceforge.net/projects/mysql]
54. Apache [http://www.apache.org]
55. Maanova Tools [http://www.jax.org/staff/churchill/labsite/software/anova/rmaanova/]
56. FatiGO [http://fatigo.bioinfo.cnio.es/]